Medplus Health Services Limited — Q1FY27 earnings call summary

Filed 22 July 2026 · Company audio recording

SSSG target remains ~10% for FY27; reassessment of full-year margin guidance post Q2.
Operating EBITDA margin at 3.5% for Q1; margin recovery expected over next quarters post cost and discount structure tweaks.
Capex plans for food park and wellness facility put on hold; core business capex continues.
Employee costs rose due to wage hikes in Karnataka (60%) and Telangana (25%+); retention bonus plan stopped for new hires from March.
Gross margin down ~200bps QoQ due to lower private label mix and higher inventory provisions; expect recovery during FY27.
FY27 net store addition guidance maintained at 800 stores, with ~50% franchisee mix.
Permanent wage cost increase due to labor code changes impacting margins.
Market feedback led to capex pause on non-core ventures; sensitivity to investor sentiment emphasized.